Skip to main content
Clinical Trials/NCT04792112
NCT04792112UnknownNot Applicable

Improving Clinical Practice Guidelines for Antenatal Corticosteroids: Incorporating a Decision Support Tool to Tackle the Uncertain Balance of Harms and Benefits

University of British Columbia4 sites in 1 country460 target enrollmentStarted: May 20, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
460
Locations
4
Primary Endpoint
The change in frequency of clinical counselling about late preterm antenatal corticosteroids.

Study Overview

Brief Summary

The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 year or older.
  • Delivered a live neonate at 34+0 to 36+6 weeks of gestation.
  • Speaks English.
  • Agrees to participate in the questionnaire during their first week post-partum.
  • Delivered at one of the six participating obstetrical hospitals.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

The change in frequency of clinical counselling about late preterm antenatal corticosteroids.

Time Frame: up to 8 months following implementation of the intervention.

The difference in the proportion of patients who delivered a neonate at 34+0 to 36+6 weeks' gestation who report having had a discussion about antenatal corticosteroids with their care provider pre-intervention versus post-intervention.

Secondary Outcomes

  • The change in quality of clinical counselling about late preterm antenatal corticosteroids as assessed by the COMRADE scale.(up to 8 months following implementation of the intervention.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jessica Liauw

Clinical Assistant Professor

University of British Columbia

Study Sites (4)

Loading locations...

Similar Trials